克罗恩病与溃疡性结肠炎的临床前蛋白质特征:大型人群队列中的巢式病例对照研究
在大型人群队列(n≥180,000)中,对日后诊断为炎症性肠病的个体与年龄性别匹配对照检测178种蛋白质,用机器学习识别临床前蛋白质特征。克罗恩病29蛋白特征在发现队列AUC=0.85、外部验证队列AUC=0.87、初始队列AUC=1.0;溃疡性结肠炎特征AUC分别为0.77、0.67、0.95。
要点
- 克罗恩病29蛋白特征在发现队列区分临床前病例与对照的AUC为0.85,外部验证队列为0.87。
- 溃疡性结肠炎临床前特征预测能力较低,发现队列AUC=0.77,验证队列AUC=0.67。
- 克罗恩病特征在双胞胎比较中,与外部健康双胞胎比较AUC=0.89,与健康同胞比较AUC=0.58(P=.04)。
核心结论
- 研究识别出可预测未来克罗恩病和溃疡性结肠病诊断的蛋白质特征,并在独立队列中验证;就克罗恩病而言,该特征具有早期预测潜力。
研究设计与样本
- 基于大型人群队列(n≥180,000)的巢式病例对照研究,血样来自日后诊断为炎症性肠病的个体及年龄性别匹配、随访期间无炎症性肠病的对照。
- 采用Olink平台检测178种蛋白质,用机器学习方法在发现队列(n=312)识别临床前疾病蛋白质特征。
- 特征在外部临床前验证队列(n=222)验证,并在初始队列(n=144)和临床前双胞胎队列(n=102)中评估。
主要发现
- 发现队列中29种蛋白质特征区分临床前克罗恩病病例与对照的AUC为0.85,临床前验证队列AUC=0.87,初始队列AUC=1.0。
- 临床前样本中,与肠道屏障完整性和巨噬细胞功能相关的下调(而非上调)蛋白质与克罗恩病诊断时间相关。
- 临床前溃疡性结肠炎特征在发现队列AUC=0.77、验证队列AUC=0.67、初始队列AUC=0.95。
- 比较临床前克罗恩病双胞胎与匹配的外部健康双胞胎时AUC=0.89,与健康同胞双胞胎比较时AUC=0.58(P=.04)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Biomarkers are needed to identify individuals at elevated risk of inflammatory bowel disease. This study aimed to identify protein signatures predictive of inflammatory bowel disease. METHODS: Using large population-based cohorts (n ≥180,000), blood samples were obtained from individuals who later in life were diagnosed with inflammatory bowel disease and compared with age and sex-matched controls, free from inflammatory bowel disease during follow-up. A total of 178 proteins were measured on Olink platforms. We used machine-learning methods to identify protein signatures of preclinical disease in the discovery cohort (n = 312). Their performance was validated in an external preclinical cohort (n = 222) and assessed in an inception cohort (n = 144) and a preclinical twin cohort (n = 102). RESULTS: In the discovery cohort, a signature of 29 proteins differentiated preclinical Crohn's disease (CD) cases from controls, with an area under the curve (AUC) of 0.85. Its performance was confirmed in the preclinical validation (AUC = 0.87) and the inception cohort (AUC = 1.0). In preclinical samples, downregulated (but not upregulated) proteins related to gut barrier integrity and macrophage functionality correlated with time to diagnosis of CD. The preclinical ulcerative colitis signature had a significant, albeit lower, predictive ability in the discovery (AUC = 0.77), validation (AUC = 0.67), and inception cohorts (AUC = 0.95). The preclinical signature for CD demonstrated an AUC of 0.89 when comparing twins with preclinical CD with matched external healthy twins, but its predictive ability was lower (AUC = 0.58; P = .04) when comparing them with their healthy twin siblings, that is, when accounting for genetic and shared environmental factors. CONCLUSION: We identified protein signatures for predicting a future diagnosis of CD and ulcerative colitis, validated across independent cohorts. In the context of CD, the signature offers potential for early prediction.
引用
- Grännö O, Bergemalm D, Salomon B, et al. Preclinical Protein Signatures of Crohn's Disease and Ulcerative Colitis: A Nested Case-Control Study Within Large Population-Based Cohorts. Gastroenterology. 2024. PMID: 39608683. doi:10.1053/j.gastro.2024.11.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。